![David Green](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of David Green
Former positions of David Green
Companies | Position | Start | End |
---|---|---|---|
AMGEN INC. | Chief Tech/Sci/R&D Officer | 1997-08-31 | 2008-01-31 |
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
UNITED THERAPEUTICS CORPORATION | Director/Board Member | - | - |
ReSearch Pharmaceutical Services, Inc. | Chief Tech/Sci/R&D Officer | - | - |
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - | - |
Statistics
International
United States | 5 |
Canada | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
AMGEN INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Private companies | 2 |
---|---|
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
ReSearch Pharmaceutical Services, Inc. |
- Stock Market
- Insiders
- David Green
- Experience